Medicaid Unwinding Disrupts Critical Medication Access for Youth with Chronic Conditions
核心洞察
Children and young adults previously covered by Medicaid (搜索) are losing access to essential medications for conditions like asthma (搜索), depression (搜索), ADHD (搜索), epilepsy (搜索), and schizophrenia (搜索) following pandemic-era coverage protections ending.
States with the largest drops in Medicaid (搜索) enrollment (17% or more) showed greater disruption in medication therapy, with patients more likely to stop filling prescriptions or resort to paying cash.
Researchers warn that medication interruptions can lead to disease flare-ups, potentially increasing school and work absenteeism among affected youth.
The post-pandemic Medicaid (搜索) "unwinding" process has significantly disrupted medication access for children and young adults with chronic conditions, according to a new study published in the journal Pediatrics. Researchers found that young people in states with the largest Medicaid enrollment drops were more likely to experience interruptions in critical medication therapies.
The study, led by Dr. Kao-Ping Chua, a pediatrician and health care researcher at the University of Michigan Medical School and School of Public Health, analyzed prescription data from 2017 to 2023, focusing on medications that treat depression (搜索), schizophrenia (搜索), ADHD (搜索), asthma (搜索), and epilepsy (搜索).
"Our findings suggest that the rapid disenrollment of young people from Medicaid (搜索) during the unwinding process resulted in the disruption of chronic disease therapy," said Dr. Chua. "As policymakers debate whether to enact drastic cuts to Medicaid funding, they should consider the possibility that doing so could similarly disrupt chronic disease therapy for children and young adults, placing them at higher risk for disease exacerbations and absenteeism from school and work."
Impact of Medicaid Enrollment Changes
During the COVID-19 pandemic, the federal government implemented a "continuous enrollment condition" that prevented states from removing people from Medicaid (搜索) rolls. This policy led to Medicaid enrollment reaching 94 million people by March 2023, an increase of 23 million from February 2020.
When this protection ended on March 31, 2023, states began reviewing their rolls to remove individuals who no longer met eligibility requirements. By September 2024, approximately 25 million adults and children had lost coverage due to this process.
The research team found stark differences between states with high and low disenrollment rates:
-
States with the largest drops in child Medicaid (搜索) enrollment (17% or more) included Arkansas, Georgia, Iowa, Idaho, Kansas, Montana, New Hampshire, Oklahoma, South Dakota, Texas, Utah, Wisconsin, and West Virginia.
-
States with the smallest drops (4% or less) included California, Connecticut, Hawaii, Illinois, Kentucky, Maryland, Maine, North Carolina, Nevada, New York, Rhode Island, Tennessee, and the District of Columbia.
Medication Disruptions Among Youth
The study utilized the IQVIA Longitudinal Prescription Database, which captures 92% of prescriptions filled in U.S. pharmacies. Researchers compared prescription patterns to data reflecting changes in child enrollment in public insurance programs from before the unwinding to the end of 2023.
For children, living in states with high Medicaid (搜索) enrollment losses was associated with:
- A larger drop in days with active prescriptions for one medication class
- A greater increase in the risk of having cash-pay prescriptions for three medication classes
The impact was even more pronounced among young adults aged 19-25, who experienced:
- Greater reduction in days with active prescriptions for two medication classes
- Increased risk of having no prescriptions across all studied medication classes
- Higher likelihood of resorting to cash payments for prescriptions
Children using asthma (搜索) inhalers were specifically noted to be more likely to decrease medication use if they lived in states with the largest drops in Medicaid (搜索) enrollment.
Clinical Implications
Regular medication adherence is crucial for conditions like depression (搜索), schizophrenia (搜索), ADHD (搜索), asthma (搜索), and epilepsy (搜索). Interruptions can lead to symptom flare-ups, disease exacerbations, and complications that affect quality of life and daily functioning.
While the researchers noted that more studies are needed to directly link these medication disruptions to worsened symptoms or health outcomes, the pattern of interrupted therapy raises significant concerns about the potential health impact on vulnerable young populations.
Current Medicaid Landscape
At the conclusion of the unwinding process, approximately 72 million Americans remained enrolled in Medicaid (搜索), with an additional 7.2 million children enrolled in the Children's Health Insurance Program (CHIP), which relies on Medicaid funding.
The study's findings come at a critical time when policymakers are debating potential changes to Medicaid (搜索) funding and eligibility requirements. Healthcare advocates emphasize that maintaining consistent coverage is essential for managing chronic conditions effectively, particularly among children and young adults who depend on regular medication therapy.
As states continue to evaluate their Medicaid (搜索) programs, this research highlights the importance of implementing strategies to minimize disruptions in care during coverage transitions, especially for those with chronic health conditions requiring ongoing medication management.